RACE ONCOLOGY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.55 AUD | +9.93% |
|
+30.25% | +84.52% |
| 26/03 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
| 18/03 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
Chart calendar Race Oncology Limited
f2b02df08f8b53550662b15dbf8dd42.XuqsjxfJMsQzbLzbneH7iMuqaR5ho8r2v_isNWuGBOY.CrDr_Gf_UbN_WvOurszDzbzdOG9W06mCzJ3-TxHVbrAPmfjCVqBRjAVa1w~653ff2aafee6201252e64320e0949173
Upcoming events on Race Oncology Limited
Past events on Race Oncology Limited
| 28/02/2024 03:14 am | Q2 2024 Earnings Release |
| 30/01/2024 07:51 am | December 2023 Sales and Revenue Release - Activities Report |
| 09/12/2023 | American Society of Hematology Meeting |
| 27/11/2023 06:30 am | Annual General Meeting |
| 23/11/2023 06:00 am | Investor Meeting |
| 23/11/2023 06:00 am | Business Update Call |
| 23/10/2023 03:54 am | September 2023 Sales and Revenue Release - Activities Report |
| 30/08/2023 09:38 am | Q4 2023 Earnings Release |
| 17/08/2023 02:00 pm | Investor Meeting |
| 15/08/2023 09:30 am | Investor Meeting |
| 11/08/2023 07:30 am | Investor Meeting |
| 09/08/2023 03:00 pm | Investor Meeting |
| 31/07/2023 04:16 am | June 2023 Sales and Revenue Release - Activities Report |
| 28/04/2023 05:10 am | March 2023 Sales and Revenue Release - Activities Report |
| 27/02/2023 11:01 am | Q2 2023 Earnings Release |
| 21/02/2023 05:00 am | Shareholders Meeting |
| 31/01/2023 05:37 am | December 2022 Sales and Revenue Release - Activities Report |
| 24/11/2022 06:30 am | Annual General Meeting |
| 27/10/2022 | September 2022 Sales and Revenue Release - Activities Report |
| 20/10/2022 12:30 pm | Investor Meeting |
Annual results
| Fiscal Period | June | 2024 |
|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 |
|
EBITDA Million AUD | Released Forecast Spread | -11,6 |
|
EBIT Million AUD | Released Forecast Spread | -11,9 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -11,7 |
|
Net income Million AUD | Released Forecast Spread | -11,7 |
|
EPS AUD | Released Forecast Spread | -0,07 |
| Announcement Date | - |
| Today 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
| 30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Race Oncology Limited
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RAC Stock
- Calendar Race Oncology Limited